出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年1月
Ophthalmic Equipment Market – Global Forecast to 2029
眼科機器市場 : デバイス (外科: 網膜硝子体、IOL、OVD、コンタクトレンズ、RGP レンズ、バックフラッシュ、診断とモニタリング: OCT、オートレフラクター、ケラトメーター、眼圧計、検眼鏡、OVD)、エンドユーザー、購入基準 – 2029年までの世界予測
Ophthalmic Equipment Market by Devices (Surgical: Vitreoretinal, IOLs, OVDs, Contact Lens, RGP Lens, Backflush; Diagnostic & Monitoring: OCT, Autorefractor, Keratometer, Tonometer, Ophthalmoscope, OVD), End User, Buying Criteria – Global Forecast to 2029
| ページ数 | 459 |
| 図表数 | 469 |
| 価格 | |
| シングルユーザライセンス | USD 7,150 |
| マルチユーザライセンス（5名） | USD 8,500 |
| コーポレート（サイト）ライセンス | USD 9,650 |
| エンタープライズライセンス | USD 11,000 |
| 種別 | 英文調査報告書 |
Report Overview
The ophthalmic equipment market is valued at an estimated USD 66.2 billion in 2023 and is projected to reach USD 88.5 billion by 2029, at a CAGR of 4.9% during the forecast period. The ophthalmic equipment market is influenced mainly by the rise in rise in eye disorders due to old age, rise in geriatric population, exposure to radiation from mobile or computer screens, increased awareness in emerging nations, rise in highly equipped clinics and hospitals due to increase in patient visits, and hereditary.
“The retinoscope segment accounted for the largest share in the ophthalmic equipment market.”
The retinoscope is a part of the ophthalmic ultrasound equipment subsegment of the diagnostic and monitoring segment. Its large share can be attributed to its advantages over traditional tools like objective measurement, such as autocorrection, accuracy of the refractive error measurement, non-invasive procedures, and minimized risk during surgeries. For example, in cataract surgery, accurate knowledge of the refractive error is essential for choosing the correct intraocular lens implant. Similarly, in refractive surgery, such as LASIK or PRK, retinoscopy is used to guide the laser to precisely correct the refractive error. Thus, it holds a major share in this segment.
“Glaucoma surgery devices are expected to grow at the highest rate in the ophthalmic surgery devices market.”
Glaucoma surgeries are on the rise mainly due to the increase in the geriatric population in emerging countries. The risk of this sight-stealing disease escalates significantly after age 40, driven by both the natural aging process and a rise in unhealthy lifestyle factors like diabetes and obesity. While this demographic shift paints a worrying picture, it’s not without its silver lining. Advanced diagnostic technologies and heightened public awareness are bringing previously hidden cases to light, and groundbreaking research into gene and stem cell therapies offers promising avenues for future treatment. However, ensuring equitable access to affordable eye care, particularly in underserved communities, remains paramount in the fight against vision loss from glaucoma. Early detection and prompt intervention are our most potent weapons in this burgeoning battle, crucial for preserving sight and upholding quality of life not just in our twilight years, but across the full spectrum of human experience.
“Asia Pacific market to witness the highest growth during the forecast period.”
During the forecast period, APAC is anticipated to grow at the fastest rate. The major factors promoting the growth of the ophthalmic equipment market in this region are awareness about rise in visits to eye clinics or hospitals right from the young age, growing old age population in emerging countries, rise in awareness of improved health diagnosis, and underlining disease like diabetes causing diabetic retinopathy.
A breakdown of the primary participants (supply-side) for the ophthalmic equipment market referred to for this report is provided below:
• By Company Type: Tier 1: 60%, Tier 2: 30%, and Tier 3: 10%
• By Designation: C-level Executives: 30%, Directors: 50%, and Others: 20%
• By Region: North America: 45%, Europe: 15%, Asia Pacific: 25%, Latin America: 10%; Middle East and Africa: 5%;
The prominent players operating in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson & Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon Inc. (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), BVI (US), DORC (Netherlands), CORZA Medical (US), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).
Research Coverage:
The market study covers the ophthalmic equipment market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by product, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall ophthalmic equipment market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
§ Analysis of key drivers (Increase in geriatric population, rising prevalence of eye disorder, technological advancements in ophthalmic devices, increased government initiatives to control visual impairment, and rising adoption of contact lenses and spectacles), restraints (high cost and risk associated with eye surgeries, increased cost of ophthalmic devices, rising adoption of refurbished ophthalmic devices), opportunities (potential growth opportunities in emerging market, low adoption of phacoemulsification devices and premium IOLs in emerging regions) and challenges (low accessibility to eye care in low-income countries and lack of skilled professionals) influencing the growth of the ophthalmic equipment market.
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the ophthalmic equipment diagnostics market. The report analyzes this market by type of product, end-user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the ophthalmic equipment diagnostics market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product, application, technology, animal type, distribution channel, end-user, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the ophthalmic equipment diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the ophthalmic equipment diagnostics market.
Table of Contents
1 INTRODUCTION 51
1.1 STUDY OBJECTIVES 51
1.2 MARKET DEFINITION AND SCOPE 51
1.2.1 INCLUSIONS & EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKETS COVERED 53
FIGURE 1 OPHTHALMIC EQUIPMENT MARKET SEGMENTATION 53
1.3.2 REGIONAL SCOPE 54
FIGURE 2 OPHTHALMIC EQUIPMENT MARKET: REGIONAL SEGMENTATION 54
1.3.3 YEARS CONSIDERED 54
1.4 CURRENCY 55
TABLE 1 USD EXCHANGE RATES 55
1.5 STAKEHOLDERS 55
1.6 SUMMARY OF CHANGES 56
1.7 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 3 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 57
2.1.1.1 Key data from secondary sources 58
2.1.2 PRIMARY DATA 59
FIGURE 4 PRIMARY SOURCES 59
2.1.2.1 Key data from primary sources 60
2.1.2.2 Key industry insights 61
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 61
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 62
2.2 MARKET SIZE ESTIMATION 62
FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 63
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BAUSCH HEALTH 63
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: OPHTHALMIC EQUIPMENT MARKET (2022) 64
FIGURE 10 BOTTOM-UP APPROACH: VISION CARE PRODUCTS COMPANY REVENUE ESTIMATION APPROACH 65
FIGURE 11 BOTTOM-UP APPROACH: SURGICAL DEVICES COMPANY REVENUE ESTIMATION APPROACH 65
FIGURE 12 BOTTOM-UP APPROACH: OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT COMPANY REVENUE ESTIMATION APPROACH 66
2.2.1 CAGR PROJECTIONS 67
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 67
2.2.2 TOP-DOWN APPROACH 67
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN OPHTHALMIC EQUIPMENT MARKET (2022–2027): IMPACT ON GROWTH & CAGR 68
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 69
FIGURE 15 DATA TRIANGULATION METHODOLOGY 69
2.4 MARKET SHARE ANALYSIS 69
2.5 STUDY ASSUMPTIONS 70
2.6 LIMITATIONS 70
2.6.1 METHODOLOGY-RELATED LIMITATIONS 70
2.6.2 SCOPE-RELATED LIMITATIONS 70
2.7 RISK ASSESSMENT 71
TABLE 2 RISK ASSESSMENT: OPHTHALMIC EQUIPMENT MARKET 71
2.8 RECESSION IMPACT ANALYSIS 71
3 EXECUTIVE SUMMARY 72
FIGURE 16 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION) 72
FIGURE 17 OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2023 VS. 2029 (USD MILLION) 73
FIGURE 18 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023 VS. 2029 (USD MILLION) 74
FIGURE 19 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023 VS. 2029 (USD MILLION) 75
FIGURE 20 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 76
FIGURE 21 REGIONAL SNAPSHOT OF OPHTHALMIC EQUIPMENT MARKET 77
4 PREMIUM INSIGHTS 78
4.1 OPHTHALMIC EQUIPMENT MARKET OVERVIEW 78
FIGURE 22 RISING PREVALENCE OF EYE DISEASES TO DRIVE MARKET GROWTH 78
4.2 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY AND END USER (2022) 79
FIGURE 23 CONSUMERS ACCOUNTED DOMINATED NORTH AMERICAN OPHTHALMIC EQUIPMENT MARKET IN 2022 79
4.3 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 80
FIGURE 24 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2029 80
4.4 OPHTHALMIC EQUIPMENT MARKET, BY REGION (2023─2029) 81
FIGURE 25 NORTH AMERICA TO LEAD MARKET UNTIL 2029 81
4.5 OPHTHALMIC EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 81
FIGURE 26 DEVELOPING MARKETS TO REGISTER FASTER GROWTH DURING FORECAST PERIOD 81
5 MARKET OVERVIEW 82
5.1 INTRODUCTION 82
5.2 MARKET DYNAMICS 82
FIGURE 27 OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 82
5.2.1 DRIVERS 83
5.2.1.1 Increasing geriatric population 83
TABLE 3 INCREASE IN GERIATRIC POPULATION, 2000–2050 83
5.2.1.2 Rising prevalence of eye disorders 83
TABLE 4 GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2022 (IN MILLION) 84
5.2.1.2.1 Cataracts 84
TABLE 5 NUMBER OF CATARACT SURGERIES, BY COUNTRY (2020 VS. 2021) 84
5.2.1.2.2 Glaucoma 85
TABLE 6 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS. 2040 (MILLION) 85
5.2.1.2.3 Obesity and diabetes 85
TABLE 7 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS. 2045 (MILLION) 86
5.2.1.2.4 Age-related macular degeneration (AMD) 86
TABLE 8 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS. 2050 (MILLION) 86
5.2.1.3 Technological advancements in ophthalmic devices 87
TABLE 9 RECENT PRODUCT LAUNCHES IN OPHTHALMIC EQUIPMENT MARKET (2020–2022) 87
5.2.1.4 Increased government initiatives to control visual impairment 87
5.2.1.5 Rising adoption of contact lenses and spectacles 88
TABLE 10 PREVALENCE AND PATIENT POPULATION FOR MYOPIA, 2020–2050 88
5.2.2 RESTRAINTS 89
5.2.2.1 High cost and risk associated with eye surgeries 89
5.2.2.2 High cost of ophthalmology devices 89
TABLE 11 PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2022) 90
5.2.2.3 Rising adoption of refurbished ophthalmic devices 90
5.2.3 OPPORTUNITIES 91
5.2.3.1 Potential growth opportunities in emerging markets 91
5.2.3.2 Low adoption of phacoemulsification devices and premium IOLs in emerging markets 91
5.2.4 CHALLENGES 92
5.2.4.1 Low accessibility to eye care in low-income countries 92
5.2.4.2 Lack of skilled professionals 92
5.3 TECHNOLOGY ANALYSIS 93
5.4 INDUSTRY TRENDS 94
5.4.1 INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY 94
5.4.2 MINIMALLY INVASIVE GLAUCOMA SURGERY 94
5.5 PRICING ANALYSIS 95
TABLE 12 REGIONAL PRICING ANALYSIS OF OPHTHALMIC EQUIPMENT, 2022 (USD) 95
5.5.1 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYER 95
TABLE 13 VISION CARE PRODUCTS PRICING ANALYSIS, BY KEY PLAYER, 2022 (USD) 95
5.5.2 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYER 96
TABLE 14 SURGICAL DEVICES PRICING ANALYSIS, BY KEY PLAYER, 2022 (USD) 96
5.5.3 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYERS 96
TABLE 15 DIAGNOSTIC & MONITORING DEVICES PRICING ANALYSIS, BY KEY PLAYER, 2022 (USD) 96
5.6 VALUE CHAIN ANALYSIS 97
FIGURE 28 OPHTHALMIC EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 97
5.7 SUPPLY CHAIN ANALYSIS 98
FIGURE 29 OPHTHALMIC EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 98
5.8 ECOSYSTEM ANALYSIS 99
FIGURE 30 OPHTHALMIC EQUIPMENT MARKET: ECOSYSTEM MAPPING 99
TABLE 16 OPHTHALMIC EQUIPMENT MARKET: ROLE IN ECOSYSTEM 100
5.9 TARIFF AND REGULATORY LANDSCAPE 100
5.9.1 REGULATORY ANALYSIS 100
5.9.2 NORTH AMERICA 100
5.9.2.1 US 100
5.9.2.2 Canada 101
5.9.3 EUROPE 101
5.9.4 ASIA PACIFIC 101
5.9.4.1 China 101
5.9.4.2 Japan 102
5.9.4.3 India 102
5.9.5 LATIN AMERICA 102
5.9.5.1 Brazil 102
5.9.5.2 Mexico 103
5.9.6 MIDDLE EAST 103
5.9.7 AFRICA 103
5.10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
5.11 PORTER’S FIVE FORCES ANALYSIS 105
TABLE 21 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 105
5.11.1 THREAT OF NEW ENTRANTS 105
5.11.2 THREAT OF SUBSTITUTES 105
5.11.3 BARGAINING POWER OF BUYERS 106
5.11.4 BARGAINING POWER OF SUPPLIERS 106
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 106
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 106
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 106
FIGURE 31 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 106
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 107
5.12.2 BUYING CRITERIA 107
FIGURE 32 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 107
TABLE 23 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 107
5.13 KEY CONFERENCES AND EVENTS IN 2023-2024 108
TABLE 24 OPHTHALMIC EQUIPMENT MARKET: CONFERENCES AND EVENTS 108
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 109
5.14.1 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGICALLY ADVANCED OPHTHALMIC EQUIPMENT 109
FIGURE 33 REVENUE SHIFT IN OPHTHALMIC EQUIPMENT MARKET 109
5.15 TRADE ANALYSIS 110
5.15.1 TRADE ANALYSIS FOR OPHTHALMIC EQUIPMENT PRODUCTS 110
TABLE 25 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION) 110
TABLE 26 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR OPHTHALMIC PRODUCTS, BY COUNTRY, 2017–2021 (USD MILLION) 110
5.16 PATENT ANALYSIS 111
5.16.1 PATENT PUBLICATION TRENDS FOR OPHTHALMIC EQUIPMENT 111
FIGURE 34 PATENT PUBLICATION TRENDS IN OPHTHALMIC EQUIPMENT MARKET, 2013–2023 111
5.16.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 111
FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR OPHTHALMIC EQUIPMENT PATENTS (JANUARY 2013–NOVEMBER 2023) 112
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR OPHTHALMIC EQUIPMENT (JANUARY 2013–NOVEMBER 2023) 112
TABLE 27 LIST OF MAJOR PATENTS/PATENT APPLICATIONS IN OPHTHALMIC EQUIPMENT MARKET 113
5.17 CASE STUDY 114
5.18 ADJACENT MARKETS 115
5.19 ARTIFICIAL INTELLIGENCE (AI) IN OPHTHALMIC EQUIPMENT 115
5.20 UNMET NEEDS/END USER EXPECTATIONS IN OPHTHALMIC EQUIPMENT 116
6 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT 117
6.1 INTRODUCTION 118
TABLE 28 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 118
6.2 VISION CARE PRODUCTS 118
TABLE 29 VISION CARE PRODUCTS OFFERED BY KEY PLAYERS 119
TABLE 30 VISION CARE PRODUCTS: OPHTHALMIC EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 120
TABLE 31 VISION CARE PRODUCTS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 121
6.2.1 SPECTACLES 122
6.2.1.1 Rising adoption of digital devices to drive market 122
TABLE 32 SPECTACLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 123
6.2.2 CONTACT LENSES 123
6.2.2.1 Increasing prevalence of vision disorders to increase demand 123
TABLE 33 CONTACT LENSES OFFERED BY KEY MARKET PLAYERS 124
TABLE 34 CONTACT LENSES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 125
6.3 SURGICAL DEVICES 126
TABLE 35 SURGICAL DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 126
TABLE 36 SURGICAL DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 127
6.3.1 CATARACT SURGICAL DEVICES 127
TABLE 37 CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 128
TABLE 38 CATARACT SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 129
6.3.1.1 Ophthalmic viscoelastic devices 129
6.3.1.1.1 Increasing number of cataract surgeries to support market growth 129
TABLE 39 OPHTHALMIC VISCOELASTIC DEVICES OFFERED BY KEY MARKET PLAYERS 130
TABLE 40 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 131
6.3.1.2 Phacoemulsification devices 131
6.3.1.2.1 Advancements in phacoemulsification devices to increase demand during forecast period 131
TABLE 41 PHACOEMULSIFICATION OFFERED BY KEY MARKET PLAYERS 132
TABLE 42 PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 133
6.3.1.3 Cataract surgical lasers 133
TABLE 43 CATARACT SURGICAL LASERS OFFERED BY KEY MARKET PLAYERS 134
TABLE 44 CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 135
TABLE 45 CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 135
6.3.1.3.1 Femtosecond lasers 136
TABLE 46 FEMTOSECOND LASERS OFFERED BY KEY MARKET PLAYERS 136
TABLE 47 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 137
6.3.1.3.2 Nd-YAG lasers 137
TABLE 48 ND-YAG LASERS OFFERED BY KEY MARKET PLAYERS 138
TABLE 49 ND-YAG LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
6.3.1.3.3 Other lasers 139
TABLE 50 OTHER LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 139
6.3.1.4 IOL injectors 140
6.3.1.4.1 Rising need for accurate implantation of IOLs to boost market growth 140
TABLE 51 IOL INJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 140
TABLE 52 IOL INJECTORS OFFERED BY KEY PLAYERS 141
6.3.1.5 Intraocular lenses 141
6.3.1.5.1 Rising prevalence of cataracts globally to propel segment 141
TABLE 53 INTRAOCULAR LENSES OFFERED BY KEY PLAYERS 142
TABLE 54 INTRAOCULAR LENSES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 143
6.3.2 VITREORETINAL SURGICAL DEVICES 143
TABLE 55 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 144
TABLE 56 VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 145
6.3.2.1 Vitrectomy machines 146
6.3.2.1.1 Vitrectomy machines widely used to correct retinal errors 146
TABLE 57 VITRECTOMY MACHINES OFFERED BY KEY MARKET PLAYERS 146
TABLE 58 VITRECTOMY MACHINES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 147
6.3.2.2 Vitreoretinal packs 147
6.3.2.2.1 Increasing awareness about vitreoretinal surgery to increase utilization of vitreoretinal packs 147
TABLE 59 VITREORETINAL PACKS OFFERED BY KEY MARKET PLAYERS 148
TABLE 60 VITREORETINAL PACKS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 148
6.3.2.3 Photocoagulation lasers 149
6.3.2.3.1 Rising prevalence of various eye diseases to drive market growth 149
TABLE 61 PHOTOCOAGULATION LASERS OFFERED BY KEY MARKET PLAYERS 149
TABLE 62 PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 150
6.3.2.4 Illumination devices 150
6.3.2.4.1 Portable, powerful illuminators widely used for greater efficiency 150
TABLE 63 ILLUMINATION DEVICES OFFERED BY KEY MARKET PLAYERS 151
TABLE 64 ILLUMINATION DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 152
6.3.2.5 Vitrectomy probes 152
6.3.2.5.1 Advancements in vitrectomy probes provide rapid cutting speed to remove vitreous bodies 152
TABLE 65 VITRECTOMY PROBES OFFERED BY KEY MARKET PLAYERS 153
TABLE 66 VITRECTOMY PROBES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 153
6.3.2.6 Backflushes 154
6.3.2.6.1 Backflushes used to prevent damage or complications to eye structure 154
TABLE 67 BACKFLUSHES OFFERED BY KEY MARKET PLAYERS 154
TABLE 68 BACKFLUSHES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 155
6.3.2.7 Chandeliers 155
6.3.2.7.1 Use of chandeliers offers improved visualization of retina 155
TABLE 69 CHANDELIERS OFFERED BY KEY MARKET PLAYERS 156
TABLE 70 CHANDELIERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 156
6.3.3 REFRACTIVE SURGICAL DEVICES 157
TABLE 71 REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 157
TABLE 72 REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 158
6.3.3.1 Femtosecond lasers 158
6.3.3.1.1 Rising preference for femtosecond lasers over microkeratomes to support market growth 158
TABLE 73 FEMTOSECOND LASERS OFFERED BY KEY MARKET PLAYERS 159
TABLE 74 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 160
6.3.3.2 Excimer lasers 160
6.3.3.2.1 Rising prevalence of myopia to drive market 160
TABLE 75 EXCIMER LASERS OFFERED BY KEY MARKET PLAYERS 161
TABLE 76 EXCIMER LASERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 162
6.3.3.3 Other refractive surgical devices 162
TABLE 77 OTHER REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 163
6.3.4 GLAUCOMA SURGICAL DEVICES 163
TABLE 78 GLAUCOMA SURGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 164
TABLE 79 GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 164
TABLE 80 GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 165
6.3.4.1 Microinvasive glaucoma surgery devices 165
6.3.4.1.1 Growing preference for microinvasive glaucoma surgery drives adoption 165
TABLE 81 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 166
6.3.4.2 Glaucoma drainage devices 167
6.3.4.2.1 Rising prevalence of glaucoma across the globe drives market growth 167
TABLE 82 GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 168
6.3.4.3 Glaucoma laser systems 168
6.3.4.3.1 Increasing prevalence of open-angle glaucoma to boost segment 168
TABLE 83 GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 169
6.3.5 OPHTHALMIC MICROSCOPES 170
6.3.5.1 Increasing prevalence of eye diseases to drive demand 170
TABLE 84 OPHTHALMIC MICROSCOPES OFFERED BY KEY MARKET PLAYERS 170
TABLE 85 OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 171
6.3.6 OPHTHALMIC SURGICAL ACCESSORIES 171
TABLE 86 OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY MARKET PLAYERS 172
TABLE 87 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE, 2021–2029 (USD MILLION) 173
TABLE 88 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 174
6.3.6.1 Surgical instruments & kits 174
6.3.6.1.1 Surgical instruments & kits hold largest share of accessories market 174
TABLE 89 SURGICAL INSTRUMENTS & KITS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 175
6.3.6.2 Ophthalmic tips & handles 176
6.3.6.2.1 Wide range of tips and handles available to meet end user demand 176
TABLE 90 OPHTHALMIC TIPS & HANDLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 176
6.3.6.3 Ophthalmic scissors 177
6.3.6.3.1 End user preference skewed toward titanium scissors 177
TABLE 91 OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 177
6.3.6.4 Ophthalmic forceps 178
6.3.6.4.1 Forceps find wide use in ophthalmological surgeries 178
TABLE 92 OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 178
6.3.6.5 Ophthalmic spatulas 179
6.3.6.5.1 China to be fastest-growing market for ophthalmic spatulas 179
TABLE 93 OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 179
6.3.6.6 Macular lenses 180
6.3.6.6.1 Rise in adoption of macular lenses witnessed for hands-free operation 180
TABLE 94 MACULAR LENSES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 180
6.3.6.7 Ophthalmic cannulas 181
6.3.6.7.1 Rising adoption of single-use cannulas to drive market growth 181
TABLE 95 OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 181
6.3.6.8 Other ophthalmic surgical accessories 182
TABLE 96 OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 182
6.4 DIAGNOSTIC & MONITORING DEVICES 183
TABLE 97 DIAGNOSTIC & MONITORING DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY TYPE, 2021–2029 (USD MILLION) 184
TABLE 98 DIAGNOSTIC & MONITORING DEVICES: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 185
6.4.1 OPTICAL COHERENCE TOMOGRAPHY SCANNERS 185
6.4.1.1 High-depth image analysis obtained in real time 185
TABLE 99 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 187
TABLE 100 OCT SCANNERS OFFERED BY KEY MARKET PLAYERS 188
6.4.2 FUNDUS CAMERAS 188
6.4.2.1 Rising prevalence of age-related disorders to boost segment 188
TABLE 101 FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS 189
TABLE 102 FUNDUS CAMERAS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 190
6.4.3 PERIMETERS/VISUAL FIELD ANALYZERS 190
6.4.3.1 Increasing incidence of glaucoma and AMD drive demand for perimeters 190
TABLE 103 PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS 191
TABLE 104 PERIMETERS/VISUAL FIELD ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 192
6.4.4 AUTOREFRACTORS & KERATOMETERS 192
6.4.4.1 Rising patient population with visual impairment to drive utilization 192
TABLE 105 AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS 193
TABLE 106 AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 194
6.4.5 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 194
TABLE 107 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2021–2029 (USD MILLION) 195
TABLE 108 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 196
6.4.5.1 A-scan ultrasound imaging systems 196
6.4.5.1.1 Most widely used to measure length of eye in common eye disorders 196
TABLE 109 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 197
TABLE 110 OPHTHALMIC A-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 198
6.4.5.2 B-scan ultrasound imaging systems 198
6.4.5.2.1 B-scans assess eye and orbit to determine eye disorders 198
TABLE 111 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 199
TABLE 112 OPHTHALMIC B-SCAN ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 199
6.4.5.3 Ultrasound biomicroscopes 200
6.4.5.3.1 Rising volume of refractive surgeries fuels market growth 200
TABLE 113 OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED BY KEY MARKET PLAYERS 200
TABLE 114 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 201
6.4.5.4 Pachymeters 201
6.4.5.4.1 Ophthalmic pachymeters widely used to monitor condition of cornea 201
TABLE 115 OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS 202
TABLE 116 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 203
6.4.6 TONOMETERS 203
6.4.6.1 Rising prevalence of glaucoma to boost demand 203
TABLE 117 TONOMETERS OFFERED BY KEY MARKET PLAYERS 204
TABLE 118 TONOMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 205
6.4.7 SLIT LAMPS 205
6.4.7.1 Rising prevalence of ocular conditions to drive market 205
TABLE 119 SLIT LAMPS OFFERED BY KEY MARKET PLAYERS 206
TABLE 120 SLIT LAMPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 207
6.4.8 PHOROPTERS 207
6.4.8.1 Phoropters aid in measurement of refractive errors 207
TABLE 121 PHOROPTERS OFFERED BY KEY MARKET PLAYERS 208
TABLE 122 PHOROPTERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 209
6.4.9 WAVEFRONT ABERROMETERS 209
6.4.9.1 Aberrometers – highly effective in measuring refractive aberrations 209
TABLE 123 WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS 210
TABLE 124 WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 210
6.4.10 OPTICAL BIOMETRY SYSTEMS 211
6.4.10.1 Advantages of optical biometry systems boost adoption in diagnostics 211
TABLE 125 OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS 211
TABLE 126 OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 212
6.4.11 OPHTHALMOSCOPES 212
6.4.11.1 Increasing number of patients with glaucoma, diabetic retinopathy, and AMD fuels market 212
TABLE 127 OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS 213
TABLE 128 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 214
6.4.12 LENSMETERS 214
6.4.12.1 Rising prevalence of myopia & hyperopia – key drivers 214
TABLE 129 LENSMETERS OFFERED BY KEY MARKET PLAYERS 215
TABLE 130 LENSMETERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 216
6.4.13 CORNEAL TOPOGRAPHY SYSTEMS 216
6.4.13.1 Increasing number of LASIK procedures drives demand 216
TABLE 131 CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS 217
TABLE 132 CORNEAL TOPOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 217
6.4.14 CHART PROJECTORS 218
6.4.14.1 Provide practitioners access to multiple chart types in one device 218
TABLE 133 CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS 218
TABLE 134 CHART PROJECTORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 219
6.4.15 SPECULAR MICROSCOPES 219
6.4.15.1 Growing number of patients with diabetes to drive market 219
TABLE 135 SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS 220
TABLE 136 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 220
6.4.16 RETINOSCOPES 221
6.4.16.1 Rising prevalence of myopia across the globe boosts market growth 221
TABLE 137 RETINOSCOPES OFFERED BY KEY MARKET PLAYERS 221
TABLE 138 RETINOSCOPES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 222
7 OPHTHALMIC EQUIPMENT MARKET, BY END USER 223
7.1 INTRODUCTION 224
TABLE 139 OPHTHALMIC EQUIPMENT MARKET BY END USER, 2021–2029 (USD MILLION) 224
7.2 CONSUMERS 224
7.2.1 RISING PREVALENCE OF OCULAR DISORDERS AND ADOPTION OF CONTACT LENSES AND SPECTACLES DRIVE MARKET GROWTH 224
TABLE 140 CONSUMERS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 225
7.3 HOSPITALS 226
7.3.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS TO DRIVE GROWTH 226
TABLE 141 HOSPITALS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 227
7.4 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS 228
7.4.1 COST-EFFECTIVENESS OF AMBULATORY CARE TO ENHANCE END USER INTEREST 228
FIGURE 37 US: NUMBER OF AMBULATORY SURGICAL CENTERS (2012–2022) 229
TABLE 142 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 230
7.5 OTHER END USERS 230
TABLE 143 OTHER END USERS: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 231
8 OPHTHALMIC EQUIPMENT MARKET, BY REGION 232
8.1 INTRODUCTION 233
FIGURE 38 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 233
8.2 NORTH AMERICA 234
8.2.1 NORTH AMERICA: RECESSION IMPACT 234
FIGURE 39 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 235
TABLE 144 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 236
TABLE 145 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 236
TABLE 146 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 237
TABLE 147 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 238
TABLE 148 NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 238
TABLE 149 NORTH AMERICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 150 NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 151 NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 152 NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 153 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 154 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 241
8.2.2 US 241
8.2.2.1 Rising geriatric population and increasing healthcare expenditure to drive market 241
TABLE 155 US: KEY MACROINDICATORS 242
TABLE 156 US: NUMBER OF OCULAR CONDITIONS, 2000–2020 (MILLION) 242
TABLE 157 US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 242
TABLE 158 US: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 243
TABLE 159 US: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 160 US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 244
TABLE 161 US: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 162 US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 163 US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 245
TABLE 164 US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 246
TABLE 165 US: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 246
TABLE 166 US: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 247
8.2.3 CANADA 247
8.2.3.1 Rising awareness about eye care and increasing ocular diseases to drive market 247
TABLE 167 CANADA: KEY MACROINDICATORS 248
TABLE 168 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 248
TABLE 169 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 170 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 171 CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 172 CANADA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 173 CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 174 CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 175 CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 176 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 177 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 253
8.3 EUROPE 253
8.3.1 EUROPE: RECESSION IMPACT 253
TABLE 178 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 254
TABLE 179 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 254
TABLE 180 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 255
TABLE 181 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 256
TABLE 182 EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 256
TABLE 183 EUROPE: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 184 EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 185 EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 257
TABLE 186 EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 187 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 188 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 259
8.3.2 GERMANY 259
8.3.2.1 Increasing healthcare expenditure to boost market 259
TABLE 189 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 260
TABLE 190 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 260
TABLE 191 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 261
TABLE 192 GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 261
TABLE 193 GERMANY: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 262
TABLE 194 GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 262
TABLE 195 GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 262
TABLE 196 GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 197 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 263
TABLE 198 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 264
8.3.3 UK 264
8.3.3.1 Rising prevalence of diabetes-related eye diseases to drive market 264
TABLE 199 UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 265
TABLE 200 UK: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 265
TABLE 201 UK: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 202 UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 203 UK: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 204 UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 205 UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 206 UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 268
TABLE 207 UK: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 268
TABLE 208 UK: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 269
8.3.4 FRANCE 269
8.3.4.1 Growing number of eye surgeries to drive demand 269
TABLE 209 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 270
TABLE 210 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 270
TABLE 211 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 271
TABLE 212 FRANCE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 271
TABLE 213 FRANCE: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 272
TABLE 214 FRANCE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 272
TABLE 215 FRANCE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 272
TABLE 216 FRANCE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 273
TABLE 217 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 273
TABLE 218 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 274
8.3.5 ITALY 274
8.3.5.1 Increasing healthcare spending and growing geriatric population to propel market 274
TABLE 219 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 275
TABLE 220 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 276
TABLE 221 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 277
TABLE 222 ITALY: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 277
TABLE 223 ITALY: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 278
TABLE 224 ITALY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 278
TABLE 225 ITALY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 278
TABLE 226 ITALY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 279
TABLE 227 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 279
TABLE 228 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 280
8.3.6 SPAIN 280
8.3.6.1 Increasing ophthalmic surgical procedures to drive market 280
TABLE 229 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 280
TABLE 230 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 281
TABLE 231 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 282
TABLE 232 SPAIN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 282
TABLE 233 SPAIN: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 234 SPAIN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 235 SPAIN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 236 SPAIN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 237 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 238 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 285
8.3.7 REST OF EUROPE 285
TABLE 239 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 286
TABLE 240 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 241 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 288
TABLE 242 REST OF EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 288
TABLE 243 REST OF EUROPE: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 244 REST OF EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 245 REST OF EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 289
TABLE 246 REST OF EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 290
TABLE 247 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 290
TABLE 248 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 291
8.4 ASIA PACIFIC 291
8.4.1 ASIA PACIFIC: RECESSION IMPACT 291
FIGURE 40 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 292
TABLE 249 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 293
TABLE 250 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 293
TABLE 251 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 294
TABLE 252 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 253 ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 254 ASIA PACIFIC: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 255 ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 256 ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 257 ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 258 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 259 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 298
8.4.2 CHINA 298
8.4.2.1 Rising prevalence of cataracts to drive market 298
TABLE 260 CHINA: KEY MACROINDICATORS 299
TABLE 261 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 299
TABLE 262 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 300
TABLE 263 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 264 CHINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 265 CHINA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 266 CHINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 267 CHINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 268 CHINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 269 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 270 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 304
8.4.3 JAPAN 304
8.4.3.1 Strong manufacturing capabilities to propel market 304
TABLE 271 JAPAN: KEY MACROINDICATORS 305
TABLE 272 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 305
TABLE 273 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 306
TABLE 274 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 275 JAPAN: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 276 JAPAN: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 277 JAPAN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 278 JAPAN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 279 JAPAN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 309
TABLE 280 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 309
TABLE 281 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 310
8.4.4 INDIA 310
8.4.4.1 Increasing geriatric population and prevalence of eye disorders to support market 310
TABLE 282 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 311
TABLE 283 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 312
TABLE 284 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 285 INDIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 286 INDIA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 287 INDIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 288 INDIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 314
TABLE 289 INDIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 315
TABLE 290 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 315
TABLE 291 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 316
8.4.5 AUSTRALIA 316
8.4.5.1 Increased cataract surgeries to drive market 316
TABLE 292 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 293 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 294 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 295 AUSTRALIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 296 AUSTRALIA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 297 AUSTRALIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 298 AUSTRALIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 299 AUSTRALIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 320
TABLE 300 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 320
TABLE 301 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 321
8.4.6 SOUTH KOREA 321
8.4.6.1 Growing focus on medical tourism to boost market 321
TABLE 302 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 322
TABLE 303 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 323
TABLE 304 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 324
TABLE 305 SOUTH KOREA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 324
TABLE 306 SOUTH KOREA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
TABLE 307 SOUTH KOREA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
TABLE 308 SOUTH KOREA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 325
TABLE 309 SOUTH KOREA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 326
TABLE 310 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 326
TABLE 311 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 327
8.4.7 REST OF ASIA PACIFIC 327
TABLE 312 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 327
TABLE 313 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 328
TABLE 314 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 329
TABLE 315 REST OF ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 329
TABLE 316 REST OF ASIA PACIFIC: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 330
TABLE 317 REST OF ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 330
TABLE 318 REST OF ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 330
TABLE 319 REST OF ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 331
TABLE 320 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 331
TABLE 321 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 332
8.5 LATIN AMERICA 332
8.5.1 LATIN AMERICA: RECESSION IMPACT 332
TABLE 322 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 333
TABLE 323 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 333
TABLE 324 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 334
TABLE 325 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 335
TABLE 326 LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 335
TABLE 327 LATIN AMERICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 328 LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 329 LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 330 LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 337
TABLE 331 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 337
TABLE 332 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 338
8.5.2 BRAZIL 338
8.5.2.1 Government support and initiatives to boost market 338
TABLE 333 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 339
TABLE 334 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 340
TABLE 335 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 341
TABLE 336 BRAZIL: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 341
TABLE 337 BRAZIL: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 338 BRAZIL: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 339 BRAZIL: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 340 BRAZIL: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 343
TABLE 341 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 343
TABLE 342 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 344
8.5.3 MEXICO 344
8.5.3.1 Growing incidence of eye disorders to drive market 344
TABLE 343 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 345
TABLE 344 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 345
TABLE 345 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 346
TABLE 346 MEXICO: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 346
TABLE 347 MEXICO: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 348 MEXICO: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 349 MEXICO: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 350 MEXICO: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 348
TABLE 351 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 348
TABLE 352 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 349
8.5.4 ARGENTINA 349
8.5.4.1 Increasing healthcare expenditure and well-developed healthcare system to favor market 349
TABLE 353 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 349
TABLE 354 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 350
TABLE 355 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 351
TABLE 356 ARGENTINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 351
TABLE 357 ARGENTINA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 352
TABLE 358 ARGENTINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 352
TABLE 359 ARGENTINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 352
TABLE 360 ARGENTINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 353
TABLE 361 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 353
TABLE 362 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 354
8.5.5 REST OF LATIN AMERICA 354
TABLE 363 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 355
TABLE 364 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 356
TABLE 365 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 357
TABLE 366 REST OF LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 357
TABLE 367 REST OF LATIN AMERICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 358
TABLE 368 REST OF LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 358
TABLE 369 REST OF LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 358
TABLE 370 REST OF LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 359
TABLE 371 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 359
TABLE 372 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 360
8.6 MIDDLE EAST & AFRICA 360
8.6.1 IMPROVING HEALTHCARE EXPENDITURE TO DRIVE MARKET 360
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 361
TABLE 373 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 361
TABLE 374 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2021–2029 (USD MILLION) 362
TABLE 375 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2021–2029 (USD MILLION) 363
TABLE 376 MIDDLE EAST & AFRICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 363
TABLE 377 MIDDLE EAST & AFRICA: CATARACT SURGICAL LASERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 364
TABLE 378 MIDDLE EAST & AFRICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 364
TABLE 379 MIDDLE EAST & AFRICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 365
TABLE 380 MIDDLE EAST & AFRICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2021–2029 (USD MILLION) 365
TABLE 381 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR VISION CARE PRODUCTS, BY TYPE, 2021–2029 (USD MILLION) 366
TABLE 382 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2021–2029 (USD MILLION) 366
9 COMPETITIVE LANDSCAPE 367
9.1 OVERVIEW 367
9.2 KEY STRATEGIES/RIGHT TO WIN 367
FIGURE 41 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN OPHTHALMIC EQUIPMENT MARKET, 2020–2023 368
9.3 REVENUE SHARE ANALYSIS 369
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS 369
9.4 MARKET SHARE ANALYSIS 370
FIGURE 43 OPHTHALMIC EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2022 370
9.5 COMPETITIVE LEADERSHIP MAPPING: KEY PLAYERS 371
9.5.1 STARS 372
9.5.2 EMERGING LEADERS 372
9.5.3 PERVASIVE PLAYERS 372
9.5.4 PARTICIPANTS 372
FIGURE 44 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2022) 373
9.5.5 COMPANY FOOTPRINT 374
TABLE 383 OVERALL COMPANY FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET 374
TABLE 384 PRODUCT FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET (2022) 375
TABLE 385 END USER FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET (2022) 376
TABLE 386 REGIONAL FOOTPRINT: OPHTHALMIC EQUIPMENT MARKET (2022) 377
9.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS 378
9.6.1 PROGRESSIVE COMPANIES 378
9.6.2 DYNAMIC COMPANIES 378
9.6.3 STARTING BLOCKS 378
9.6.4 RESPONSIVE COMPANIES 378
FIGURE 45 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2022) 379
9.6.5 COMPETITIVE BENCHMARKING FOR START-UPS 380
9.7 COMPETITIVE SCENARIOS AND TRENDS 380
9.7.1 PRODUCT LAUNCHES 380
TABLE 387 OPHTHALMIC EQUIPMENT MARKET: PRODUCT LAUNCHES, 2020–2023 380
9.7.2 DEALS 381
TABLE 388 OPHTHALMIC EQUIPMENT MARKET: DEALS, 2020–2023 381
9.7.3 OTHER DEVELOPMENTS 382
TABLE 389 OPHTHALMIC EQUIPMENT MARKET: OTHER DEVELOPMENTS, 2020–2023 382
10 COMPANY PROFILES 383
10.1 KEY PLAYERS 383
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 BAUSCH HEALTH COMPANIES INC. 383
TABLE 390 BAUSCH HEALTH COMPANIES INC.: BUSINESS OVERVIEW 383
FIGURE 46 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2022) 384
10.1.2 ALCON 388
TABLE 391 ALCON: BUSINESS OVERVIEW 388
FIGURE 47 ALCON: COMPANY SNAPSHOT (2022) 389
10.1.3 CARL ZEISS MEDITEC AG 393
TABLE 392 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW 393
FIGURE 48 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2022) 394
10.1.4 JOHNSON & JOHNSON 398
TABLE 393 JOHNSON & JOHNSON: BUSINESS OVERVIEW 398
FIGURE 49 JOHNSON & JOHNSON VISION CARE: COMPANY SNAPSHOT (2022) 399
10.1.5 HOYA CORPORATION 404
TABLE 394 HOYA CORPORATION: BUSINESS OVERVIEW 404
FIGURE 50 HOYA CORPORATION: COMPANY SNAPSHOT (2022) 405
10.1.6 THE COOPER COMPANIES, INC. 409
TABLE 395 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW 409
FIGURE 51 THE COOPER COMPANIES, INC. (COOPERVISION): COMPANY SNAPSHOT (2022) 410
10.1.7 ESSILORLUXOTTICA 413
TABLE 396 ESSILORLUXOTTICA: BUSINESS OVERVIEW 413
FIGURE 52 ESSILORLUXOTTICA: COMPANY SNAPSHOT (2022) 414
10.1.8 CANON 418
TABLE 397 CANON: BUSINESS OVERVIEW 418
FIGURE 53 CANON: COMPANY SNAPSHOT (2022) 419
10.1.9 GLAUKOS CORPORATION 420
TABLE 398 GLAUKOS CORPORATION: BUSINESS OVERVIEW 420
FIGURE 54 GLAUKOS CORPORATION: COMPANY SNAPSHOT (2022) 421
10.1.10 NIDEK CO., LTD. 424
TABLE 399 NIDEK: BUSINESS OVERVIEW 424
10.1.11 TOPCON 428
TABLE 400 TOPCON: BUSINESS OVERVIEW 428
FIGURE 55 TOPCON: COMPANY SNAPSHOT (2022) 429
10.1.12 ZEIMER OPHTHALMIC SYSTEMS 432
TABLE 401 ZEIMER OPHTHALMIC SYSTEMS: BUSINESS OVERVIEW 432
10.1.13 STAAR SURGICAL 434
TABLE 402 STAAR SURGICAL: BUSINESS OVERVIEW 434
FIGURE 56 STAAR SURGICAL: COMPANY SNAPSHOT (2022) 435
10.1.14 HAAG-STREIT 437
TABLE 403 HAAG-STREIT: BUSINESS OVERVIEW 437
10.1.15 QUANTEL MEDICAL 440
TABLE 404 QUANTEL MEDICAL: BUSINESS OVERVIEW 440
10.1.16 COBURN TECHNOLOGIES, INC. 442
TABLE 405 COBURN TECHNOLOGIES, INC.: BUSINESS OVERVIEW 442
10.1.17 FCI OPHTHALMICS 444
TABLE 406 FCI OPHTHALMICS: BUSINESS OVERVIEW 444
10.1.18 MATRONIX INDIA CORPORATION 447
TABLE 407 MATRONIX INDIA CORPORATION: BUSINESS OVERVIEW 447
10.1.19 HEINE OPTOTECHNIK 449
TABLE 408 HEINE OPTOTECHNIK: BUSINESS OVERVIEW 449
10.1.20 VISIONIX 451
TABLE 409 VISIONIX: BUSINESS OVERVIEW 451
10.1.21 NEO VISION 454
TABLE 410 NEO VISION: BUSINESS OVERVIEW 454
10.1.22 BVI 455
TABLE 411 BVI: BUSINESS OVERVIEW 455
10.1.23 DUTCH OPHTHALMIC RESEARCH CENTRE 456
TABLE 412 DORC: BUSINESS OVERVIEW 456
10.1.24 CORZA 457
TABLE 413 CORZA MEDICAL: BUSINESS OVERVIEW 457
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS 459
10.2.1 CLEAR LAB 459
10.2.2 APPASAMY ASSOCIATES 460
10.2.3 OPHTEC BV 461
10.2.4 LUMENIS 462
10.2.5 INTUVISION LABS 463
11 APPENDIX 464
11.1 DISCUSSION GUIDE 464
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 470
11.3 CUSTOMIZATION OPTIONS 472
11.4 RELATED REPORTS 473
11.5 AUTHOR DETAILS 474